Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: A prospective study

International Journal of Clinical Practice

Volumn 66, Issue 5, 2012, Pages 504-514

  Mattarozzi, K ^a   Vignatelli, L ^b   Baldin, E ^c   Lugaresi, A ^d   Pietrolongo, E ^d   Tola, M R ^e   Motti, L ^f   Neri, W ^g   Calzoni, S ^h   Granella, F ⁱ   Galeotti, M ^j   Santangelo, M ^k   Malagu', S ^l   Fiorani, L ^m   Guareschi, A ⁿ   Scandellari, C ^o   D'Alessandro, R ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b City of Bologna Local Health Trust   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g MORGAGNI PIERANTONI HOSPITAL   (Italy)

^h MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

ⁱ UNIVERSITY OF PARMA   (Italy)

^j Neurology Unit   (Italy)

^k Ramazzini Hospital   (Italy)

^l BUFALINI HOSPITAL   (Italy)

^m Hospital of Faenza   (Italy)

ⁿ Fidenza Hospital   (Italy)

^o Multiple Sclerosis Center   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; AWARENESS; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MOOD; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RATING SCALE; SCREENING TEST;

ADOLESCENT; ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DISCLOSURE; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 84860163586     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02912.x     Document Type: Article

References (19)

1. McDonald WI, Compston A, Edan G, et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
2. Polman CH, Reingold SC, Edan G, et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-6. (Pubitemid 41746873)
3. Heesen C, Kolbeck J, Gold SM, Schulz H, Schulz KH,. Delivering the diagnosis of MS-results of a survey among patients and neurologists. Acta Neurol Scand 2003; 107: 363-8. (Pubitemid 36628361)
4. Janssens AC, de Boer JB, Kalkers NF, Passchier J, van Doorn PA, Hintzen RQ,. Patients with multiple sclerosis prefer early diagnosis. Eur J Neurol 2004; 11: 335-7. (Pubitemid 38903567)
5. Papathanasopoulos PG, Nikolakopoulou A, Scolding NJ,. Disclosing the diagnosis of multiple sclerosis. J Neurol 2005; 252: 1307-9. (Pubitemid 41699018)
6. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M,. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005; 4: 281-8. (Pubitemid 40545039)
7. D'Alessandro R, Baldin E, Delaj L, et al., GERONIMUS study: progression rates to multiple sclerosis according to McDonald and Poser Criteria in patients with clinically isolated syndrome. On behalf of the GERONIMUS Study Group [abstract 62nd Annual Meeting of American Academy of Neurology]. Neurology, 2010; 74 (Suppl. 2): P37.
8. Solari A, Filippini G, Mendozzi L, et al., Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999; 67: 158-62. (Pubitemid 29326944)
9. Hickey AM, Bury G, O'Boyle CA, Bradley F, O'Kelly FD, Shannon W,. A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. BMJ 1996; 313: 29-33. (Pubitemid 26229887)
10. Spielberger CD, Gorsuch RL, Lushene RE,. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
11. Solari A, Motta A, Mendozzi L, et al., Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis. Neurol Sci 2003; 24: 371-9.
12. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52. (Pubitemid 14237132)
13. Cohen J,. A power primer. Psychol Bull 1992; 112: 155-9.
14. Fava GA, Sonino N,. Psychosomatic medicine. Int J Clin Pract 2010; 64: 1155-61.
15. Atesci FC, Baltalarli B, Oguzhanoglu NK, Karadag F, Ozdel O, Karagoz N,. Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer 2004; 12: 161-7. (Pubitemid 38374676)
16. Roll IJ, Simms V, Harding R,. Multidimensional problems among advanced cancer patients in Cuba: awareness of diagnosis is associated with better patient status. J Pain Symptom Manage 2009; 37: 325-30.
17. Montazeri A, Tavoli A, Mohagheghi MA, Roshan R, Tavoli Z,. Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere? BMC Cancer 2009; 9: 39-47.
18. Montazeri A, Hole D, Milory R, McEwen J, Gills CR,. Does knowledge of cancer diagnosis affect quality of life? A methodological challenge. BMC Cancer 2004; 4: 21.
19. Heesen C, Solari A, Giordano A, Kasper J, Köpke S,. Decisions on multiple sclerosis immunotherapy: new treatment complexities urge patient engagement. J Neurol Sci 2010; 15: 192-7.